Product Program year 2025 Source: CMS Open Payments

Clinical Trial Product

Device Clinical Trial Product_NMD

Open in the dashboard

General payments

$40,166

1,148 payments

Research payments

$1,461,068

89 payments

Through program year 2025, $40,166 in general payments and $1,461,068 in research payments were reported against Clinical Trial Product (Clinical Trial Product_NMD).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $24,333 574
2025 Research $1,451,068 88
2024 Research $10,000 1
2022 General $15,832 574

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $40,166 1,148 payments
Top recipients General payments · program year 2025
  1. Jad Khalil Orthopaedic Surgery · Southfield, MI $6,058 25% · 4 payments
  2. Stephen Pyles Pain Medicine · Ocala, FL $1,900 8% · 1 payment
  3. Dan Nguyen Neuroradiology · Washington, DC $1,120 5% · 4 payments
  4. Jeremy Barlow Pain Medicine · Vestavia Hills, AL $373 2% · 5 payments
  5. Anjum Bux Pain Medicine · Danville, KY $327 1% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pain Medicine Anesthesiology $6,729 28% · 63 practitioners
  2. Orthopaedic Surgery $6,386 26% · 10 practitioners
  3. Interventional Pain Medicine Pain Medicine $2,522 10% · 46 practitioners
  4. Physical Medicine & Rehabilitation $1,126 5% · 18 practitioners
  5. Neuroradiology Radiology $1,120 5% · 1 practitioner

The top 5 of 33 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Michigan $6,220 26% · 5 recipients
  2. Florida $2,754 11% · 17 recipients
  3. Texas $2,084 9% · 35 recipients
  4. Ohio $1,886 8% · 15 recipients
  5. Kentucky $1,805 7% · 15 recipients

The top 5 of 31 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,148 general · 89 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record